Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-12-01

FDA Approved: CICLOPIROX — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved a supplemental application for Ciclopirox from Glenmark Pharmaceuticals Inc., USA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ciclopirox (ciclopirox)

Snippet

SUPPL AP for CICLOPIROX (CICLOPIROX)